|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/5575 | |||
| A61K 47/34 |
| (11) | Number of the document | 2525776 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11701723.6 |
| Date of filing the European patent application | 2011-01-21 | |
| (97) | Date of publication of the European application | 2012-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/021971 |
| Date | 2011-01-21 |
| (87) | Number | WO 2011/091205 |
| Date | 2011-07-28 |
| (30) | Number | Date | Country code |
| 297660 P | 2010-01-22 | US |
| (72) |
ROBINSON, Michael R., US
BURKE, James, US
SCHIFFMAN, Rhett, US
GHEBREMESKEL, Alazar N., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS |
| INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS |